Chronoepileptology: Mapping the Rhythms of Seizure Risk
Open Access
- 31 October 2025
- journal article
- review article
- Published by SAGE Publications in Epilepsy Currents
- Vol. 26 (2) , 93-98
Abstract
Seizure occurrence in epilepsy is governed by biological rhythms, challenging the traditional view of seizures as random events. Circadian and multidien cycles shape seizure risk, with patient-specific chronotypes and stable temporal patterns observed across epilepsy types. The Molecular Oscillations and Rhythmicity of Epilepsy hypothesis posits that molecular oscillations—particularly those involving core clock genes and region-specific protein expression—create dynamic windows of increased seizure susceptibility. In epilepsy, these rhythms are altered, amplifying seizure risk through metabolic and genetic reorganization. Seizure timing is also modulated by hormonal cycles in women with catamenial epilepsy. Estrogen promotes seizures, while progesterone and its metabolite allopregnanolone are protective. Three distinct catamenial patterns guide diagnosis and treatment, though evidence for hormonal therapies remains limited. Personalized approaches, including adjunctive medications and cycle-specific dosing, may reduce seizure burden. Importantly, sudden unexpected death in epilepsy predominantly occurs at night, implicating sleep, circadian timing, and environmental factors. Nocturnal vulnerability is conserved across species, suggesting a biological mechanism potentially involving serotonin, which regulates respiration, cardiac function, and arousal. Finally, chronotherapeutic approaches offer a promising avenue for epilepsy management by aligning treatment with seizure timing. Time-adjusted dosing of antiseizure medications has shown improved outcomes in patients with predictable seizure patterns. Future strategies may include closed-loop systems and biomarker-guided interventions to shift seizure susceptibility rhythms. Together, these findings underscore the importance of temporal biology in epilepsy. Understanding when seizures occur provides insight into why they occur, paving the way for personalized, rhythm-informed care that enhances prediction, prevention, and treatment.Keywords
This publication has 60 references indexed in Scilit:
- Neurosteroid Withdrawal Model of Perimenstrual Catamenial EpilepsyEpilepsia, 2001
- Anti-seizure effects of progesterone and 3α,5α-THP in kainic acid and perforant pathway models of epilepsyPsychoneuroendocrinology, 2000
- Seizure Activity Is Increased in Endocrine States Characterized by Decline in Endogenous Levels of the Neurosteroid 3α,5α-THPNeuroendocrinology, 1998
- Three Patterns of Catamenial EpilepsyEpilepsia, 1997
- The neurosteroid 3α,5α-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsyBrain Research, 1995
- The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patientsJournal of Neurology, 1992
- Treatment of seizures with medroxyprogesterone acetateNeurology, 1984
- CLOBAZAM IN CATAMENIAL EPILEPSYThe Lancet, 1982
- EPILEPTIC SEIZURES IN WOMEN RELATED to PLASMA ESTROGEN and PROGESTERONE DURING the MENSTRUAL CYCLEActa Neurologica Scandinavica, 1976
- Modification of therapy for exacerbation of seizures during menstruationThe Journal of Pediatrics, 1974